CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-02 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2024-03-29 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +47,088 | 47,088 | ||
| 2024-03-29 | Capponi Vincent President and COO | Grant or award · Stock Option (Right to Buy) | +48,923 | 48,923 | ||
| 2024-03-29 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +49,038 | 49,038 | ||
| 2024-03-29 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +129,998 | 129,998 | ||
| 2023-12-13 | Sobel Alan D. Director | Purchase | +22,557 | $1.33 | $30K | 101,857 |
| 2023-12-13 | Sobel Alan D. Director | Purchase · Common Stock Warrant (Right to Buy) | +7,894 | 7,894 | ||
| 2023-12-13 | Deliargyris Efthymios Chief Medical Officer | Purchase | +22,557 | $1.33 | $30K | 348,433 |
| 2023-12-13 | Deliargyris Efthymios Chief Medical Officer | Purchase · Common Stock Warrant (Right to Buy) | +7,894 | 7,894 | ||
| 2023-12-13 | Capponi Vincent President & COO | Purchase | +18,797 | $1.33 | $25K | 584,134 |
| 2023-12-13 | Capponi Vincent President & COO | Purchase · Common Stock Warrant (Right to Buy) | +6,578 | 6,578 | ||
| 2023-12-13 | BATOR MICHAEL G. Director | Purchase | +37,594 | $1.33 | $50K | 125,394 |
| 2023-12-13 | BATOR MICHAEL G. Director | Purchase · Common Stock Warrant (Right to Buy) | +13,157 | 13,157 | ||
| 2023-12-13 | Jones Edward Raymond Director | Purchase | +7,519 | $1.33 | $10K | 88,834 |
| 2023-12-13 | Jones Edward Raymond Director | Purchase · Common Stock Warrant (Right to Buy) | +2,631 | 2,631 | ||
| 2023-12-13 | BLOCH KATHLEEN P. Chief Financial Officer | Purchase | +37,594 | $1.33 | $50K | 467,941 |
| 2023-12-13 | BLOCH KATHLEEN P. Chief Financial Officer | Purchase · Common Stock Warrant (Right to Buy) | +13,157 | 13,157 | ||
| 2023-12-13 | Kim Jiny Director | Purchase | +7,519 | $1.33 | $10K | 77,819 |
| 2023-12-13 | Kim Jiny Director | Purchase · Common Stock Warrant (Right to Buy) | +2,631 | 2,631 | ||
| 2023-12-13 | Chan Phillip P. Chief Executive Officer | Purchase | +75,188 | $1.33 | $100K | 1,068,704 |
Page 5 of 35 · 698 trades